Thula Rajasingham

Thulashitha Rajasingham is a seasoned scientist with extensive experience in the biomedical field, currently serving as a Senior Scientist and Clinical Pharm Lead for MLBio’s LGMD2I program at BridgeBio since December 2018. Rajasingham's expertise encompasses both pre-clinical and clinical environments, with contributions to biomarker discovery and assay development. Previous positions include Associate Scientist at BioAge Labs, Scientist and Operations Lead at Prospect Bio, and various roles at Stanford University School of Medicine and UCL Cancer Institute, focusing on cell culture, clinical trials, and experimental design. Rajasingham holds an MSc in Biomedical Science from Kingston University, a BSc in Genetics, Microbiology, and Chemistry from Bangalore University, and a diploma in Medical Genetics from Eauclaire Institute.